• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pathophysiological mechanisms underlying early brain injury and delayed cerebral ischemia in the aftermath of aneurysmal subarachnoid hemorrhage: a comprehensive analysis.

作者信息

Stragier Hendrik, Vandersmissen Hans, Ordies Sofie, Thiessen Steven, Mesotten Dieter, Peuskens Dieter, Ten Cate Hugo

机构信息

Department of Anaesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Therapy, Ziekenhuis Oost-Limburg, Genk, Belgium.

CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.

出版信息

Front Neurol. 2025 May 23;16:1587091. doi: 10.3389/fneur.2025.1587091. eCollection 2025.

DOI:10.3389/fneur.2025.1587091
PMID:40488203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12142988/
Abstract
摘要

相似文献

1
Pathophysiological mechanisms underlying early brain injury and delayed cerebral ischemia in the aftermath of aneurysmal subarachnoid hemorrhage: a comprehensive analysis.动脉瘤性蛛网膜下腔出血后早期脑损伤和迟发性脑缺血的病理生理机制：综合分析
Front Neurol. 2025 May 23;16:1587091. doi: 10.3389/fneur.2025.1587091. eCollection 2025.
2
Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies.颅内动脉瘤性蛛网膜下腔出血：病理生理学与治疗策略综述。
Curr Neurol Neurosci Rep. 2021 Jul 26;21(9):50. doi: 10.1007/s11910-021-01136-9.
3
Early and delayed blood-brain barrier permeability predicts delayed cerebral ischemia and outcomes following aneurysmal subarachnoid hemorrhage.早期和延迟的血脑屏障通透性可预测动脉瘤性蛛网膜下腔出血后的迟发性脑缺血和结局。
Eur Radiol. 2024 Aug;34(8):5287-5296. doi: 10.1007/s00330-023-10571-w. Epub 2024 Jan 15.
4
Increased brain volume in the early phase of aneurysmal subarachnoid hemorrhage leads to delayed cerebral ischemia.动脉瘤性蛛网膜下腔出血早期脑容量增加会导致迟发性脑缺血。
Front Surg. 2024 Sep 19;11:1467154. doi: 10.3389/fsurg.2024.1467154. eCollection 2024.
5
Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II).镁治疗和血糖水平对蛛网膜下腔出血患者迟发性脑缺血的影响：Magnesium in Aneurysmal Subarachnoid Haemorrhage trial（MASH-II）的子研究。
Int J Stroke. 2015 Oct;10 Suppl A100:108-12. doi: 10.1111/ijs.12621.
6
Blood free Radicals Concentration Determined by Electron Paramagnetic Resonance Spectroscopy and Delayed Cerebral Ischemia Occurrence in Patients with Aneurysmal Subarachnoid Hemorrhage.通过电子顺磁共振光谱法测定的血液自由基浓度与动脉瘤性蛛网膜下腔出血患者迟发性脑缺血的发生情况
Cell Biochem Biophys. 2017 Dec;75(3-4):351-358. doi: 10.1007/s12013-017-0820-7. Epub 2017 Sep 25.
7
Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage - Serum D-dimer and C-reactive Protein as Early Markers.动脉瘤性蛛网膜下腔出血患者的迟发性脑缺血——血清D-二聚体和C反应蛋白作为早期标志物
J Stroke Cerebrovasc Dis. 2020 Mar;29(3):104558. doi: 10.1016/j.jstrokecerebrovasdis.2019.104558. Epub 2019 Dec 28.
8
Role of Anesthetics and Their Adjuvants in Neurovascular Protection in Secondary Brain Injury after Aneurysmal Subarachnoid Hemorrhage.麻醉药物及其佐剂在动脉瘤性蛛网膜下腔出血后二次脑损伤中的神经血管保护作用。
Int J Mol Sci. 2021 Jun 18;22(12):6550. doi: 10.3390/ijms22126550.
9
Emerging Markers of Early Brain Injury and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血早期脑损伤和迟发性脑缺血的新兴标志物
World Neurosurg. 2017 Nov;107:148-159. doi: 10.1016/j.wneu.2017.07.114. Epub 2017 Jul 27.
10
An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.蛛网膜下腔出血后脑血管痉挛和迟发性脑缺血的药物治疗概述。
Expert Opin Pharmacother. 2021 Aug;22(12):1601-1614. doi: 10.1080/14656566.2021.1912013. Epub 2021 Apr 13.

本文引用的文献

1
Neuroinflammatory response after subarachnoid hemorrhage: A review of possible treatment targets.蛛网膜下腔出血后的神经炎症反应：潜在治疗靶点综述
Clin Neurol Neurosurg. 2025 May;252:108843. doi: 10.1016/j.clineuro.2025.108843. Epub 2025 Mar 16.
2
NLRP3 inflammasome in neuroinflammation and central nervous system diseases.NLRP3炎性小体在神经炎症和中枢神经系统疾病中的作用
Cell Mol Immunol. 2025 Apr;22(4):341-355. doi: 10.1038/s41423-025-01275-w. Epub 2025 Mar 13.
3
Effectiveness of human albumin for clinical outcome in aneurysmal subarachnoid hemorrhages: a protocol for randomized controlled (HASH) trial.
人血白蛋白对动脉瘤性蛛网膜下腔出血临床结局的有效性：一项随机对照（HASH）试验方案
Trials. 2025 Feb 14;26(1):53. doi: 10.1186/s13063-025-08762-5.
4
Predicting prognosis using stroke-heart indicator: brain natriuretic peptide in patients with aneurysmal subarachnoid hemorrhage.使用卒中-心脏指标预测预后：脑钠肽在动脉瘤性蛛网膜下腔出血患者中的应用
Front Neurol. 2025 Jan 22;16:1510235. doi: 10.3389/fneur.2025.1510235. eCollection 2025.
5
Update on Strategies to Reduce Early Brain Injury after Subarachnoid Hemorrhage.蛛网膜下腔出血后减少早期脑损伤的策略最新进展
Curr Neurol Neurosci Rep. 2024 Dec 26;25(1):14. doi: 10.1007/s11910-024-01396-1.
6
Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Are Old Data Enough to Justify Its Current Treatment Regimen?尼莫地平用于动脉瘤性蛛网膜下腔出血：旧数据是否足以证明其当前治疗方案的合理性？
Neurocrit Care. 2025 Apr;42(2):334-340. doi: 10.1007/s12028-024-02182-0. Epub 2024 Dec 17.
7
Dexmedetomidine is Associated with Reduced In-Hospital Mortality Risk of Patients with Subarachnoid Hemorrhage Undergoing Surgery.右美托咪定与蛛网膜下腔出血手术患者住院死亡率降低相关。
World Neurosurg. 2025 Feb;194:123539. doi: 10.1016/j.wneu.2024.11.122. Epub 2024 Dec 23.
8
Perivascular Neutrophil Extracellular Traps Exacerbate Microvasospasm After Experimental Subarachnoid Hemorrhage.实验性蛛网膜下腔出血后血管周围中性粒细胞细胞外陷阱加重微血管痉挛。
Stroke. 2024 Dec;55(12):2872-2881. doi: 10.1161/STROKEAHA.124.047574. Epub 2024 Oct 30.
9
Targeting NETosis in Acute Brain Injury: A Systematic Review of Preclinical and Clinical Evidence.靶向急性脑损伤中的 NETosis：临床前和临床证据的系统评价。
Cells. 2024 Sep 14;13(18):1553. doi: 10.3390/cells13181553.
10
The Impact of Sedative Choice in the Management of Aneurysmal Subarachnoid Hemorrhage: A Scoping Review.镇静剂选择在动脉瘤性蛛网膜下腔出血管理中的影响：一项范围综述
Neurocrit Care. 2025 Apr;42(2):668-679. doi: 10.1007/s12028-024-02111-1. Epub 2024 Sep 12.